Why are Indian shares expected to open little changed despite the Federal Reserve holding interest rates steady?

Indian shares are expected to open little changed because although the Federal Reserve held rates steady as expected, its chair's 'unwavering commitment to bring inflation down' and a notable split among policymakers — with three of 12 committee members dissenting — created confusion among investors about the future path of monetary policy, leading to cautious sentiment and muted market reaction.

What significant regulatory development did Sun Pharma achieve according to the news?

Sun Pharma received approval in Brazil to manufacture and market semaglutide, a key GLP-1 receptor agonist used for diabetes and obesity treatment.

Indian Shares Seen Muted on Fed Rates Confusion; Sun Pharma Wins Brazil Approval

Jul 29, 2026

Indian shares opened little changed after the Federal Reserve held rates steady, amidst geopolitical risks pushing Brent crude lower. Meanwhile, Sun Pharma gained approval to manufacture semaglutide in Brazil.

reuters

2026-04-26

India's Sun Pharma to Buy Organon in $11.75 Billion All-Cash Deal

2026-04-28

Sun Pharma to Buy Organon for More Than $11 Billion

2026-06-20

Sun Pharma to acquire Innovcare Lifesciences for $28.7 million

2026-07-29

Indian Shares Seen Muted on Fed Rates Confusion; Sun Pharma Wins Brazil Approval

Indian Shares Seen Muted on Fed Rates Confusion; Sun Pharma Wins Brazil Approval

FAQ